Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

USPX vs SPXV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

USPX Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

USPX Overall Winner 6-Pillar Tally: USPX 0 – 0 SPXV (6 Tie) Matrix Metrics: USPX 3 – 0 SPXV

As of Nov 20, 2026, Franklin U.S. Equity Index ETF (USPX) is the stronger overall head-to-head candidate over ProShares S&P 500 Ex-Health Care ETF (SPXV) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). USPX carries a Unified Composite Score of 39.9/100 (SELL) at $60.22 (N/M Forward P/E, N/A operating margin), whereas SPXV carries 39.6/100 (SELL) at $74.11 (N/M Forward P/E, N/A operating margin).

  • Defensive Composite Rating Caution: Although USPX compares more favorably head-to-head, both USPX (39.9/100 SELL) and SPXV (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: USPX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.8); meanwhile SPXV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About USPX vs SPXV
USPX NYSE Arca Head-to-Head Winner
Franklin U.S. Equity Index ETF
Institutional Equity
$60.22
-3.69% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.00β · 24% Vol
Unified Composite Score
39.9 / 100 SELL
Tech 14.0 Fund 44.0 Flow 50.0 Mom 65.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.0%), weak momentum, RSI 25
RSI-14: 24.8 · SMA20: $65.32 · SMA50: $66.48
SPXV NYSE Arca
ProShares S&P 500 Ex-Health Care ETF
Institutional Equity
$74.11
-4.37% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.04β · 25% Vol
Unified Composite Score
39.6 / 100 SELL
Tech 13.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 25
RSI-14: 24.7 · SMA20: $80.89 · SMA50: $82.81

6-Pillar Scorecard Institutional Category Breakdown (USPX 0 – 0 SPXV)

Columns: Metric · USPX · SPXV
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 221.1% (92nd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: USPX (3) vs SPXV (0)
Institutional Metric USPX SPXV Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
39% ($55–$68) 31% ($69–$86) Stronger Trend USPX
Beta / 30D Volatility
Risk Regime
1.00β · 24% Vol 1.04β · 25% Vol Lower Realized Risk USPX
Unified Institutional Score
Composite Signal
39.9 / 100 (SELL) 39.6 / 100 (SELL) Higher Composite USPX
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon USPX +0.87 pp
USPX: -9.82% · SPXV: -10.69%
3M Horizon USPX +1.31 pp
USPX: -9.72% · SPXV: -11.03%
6M Horizon USPX +2.49 pp
USPX: -7.57% · SPXV: -10.06%
1Y Horizon USPX +0.9 pp
USPX: +3.45% · SPXV: +2.55%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on USPX vs SPXV. Trailing 12-month operating profitability (USPX N/A vs SPXV N/A) and valuation multiples (USPX N/M vs SPXV N/M Forward P/E) are benchmarked directly in Pillar 4 below.

USPX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SPXV ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
USPX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact USPX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SPXV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 221.1%
IV Percentile 92nd %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SPXV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
USPX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SPXV Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ USPX vs SPXV Key Questions & Quantitative Answers

As of Nov 20, 2026, Franklin U.S. Equity Index ETF (USPX) is the stronger overall head-to-head candidate over ProShares S&P 500 Ex-Health Care ETF (SPXV) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). USPX carries a Unified Composite Score of 39.9/100 (SELL) at $60.22 (N/M Forward P/E, N/A operating margin), whereas SPXV carries 39.6/100 (SELL) at $74.11 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although USPX compares more favorably head-to-head, both USPX (39.9/100 SELL) and SPXV (39.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: USPX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.8); meanwhile SPXV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

USPX and SPXV split Growth & Scale metrics: USPX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SPXV at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, USPX generates N/A in USD-normalized revenue versus N/A for SPXV. In operating R&D and SG&A reinvestment, USPX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SPXV.

USPX and SPXV trade at balanced relative valuation multiples. USPX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SPXV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against USPX (N/A ROE) versus SPXV (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, USPX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.00β · 24% Vol realized risk). By comparison, SPXV carries 221.1% implied volatility (92nd %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 25% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.